Join Growin Stock Community!

Royalty pharma plc(RPRX.US Overview)

US StockHealthcare
No presentation for RPRX

RPRX AI Insights

RPRX Overall Performance

RPRX AI Analysis & Strategy

RPRX Recent Performance

-1.13%

Royalty pharma plc

-0.68%

Avg of Sector

-1.92%

S&P 500

RPRX PowerScanner

RPRX Key Information

RPRX Valuation Metrics

RPRX Earnings Table

RPRX Profile

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

Price of RPRX

RPRX FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer